MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Eccogene
- Study ID
- NCT07505303
- Phase
- PHASE2
- Status
- Active Not Recruiting
Conditions
- Adult Obesity
- Weight Management
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- ECC4703 — DRUGorally QD
- Placebo — DRUGorally QD
- Semaglutide — DRUGSC once weekly
Study Details
The primary objective of this trial is to evaluate the effect of oral ECC4703 on body weight reduction and in a sub-study on liver fat content as assessed by change in magnetic resonance imaging proton density fat fraction (MRI-PDFF) at Week 20.
Key Dates
- Start date
- Mar 23, 2026
- Status verified
- Jun 2026
- Primary completion
- Oct 15, 2026
- Completion
- Oct 15, 2026
Study Design
- Enrollment
- 151 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Arm 1: ECC4703 + semaglutideECC4703 orally QD + semaglutide SC once weekly
- Placebo Comparator: Arm 2: Placebo + semaglutidePlacebo orally QD + semaglutide SC once weekly
Primary Outcome Measure
Percentage Change in Body Weight from Baseline (Week 9) to Week 20 [ Time Frame: Baseline (Week 9) to Week 20 ]
Locations (15)
Find similar trials in Birmingham, AL
By research site
Central Research Associates - Flourish - PPDS· Birmingham, ALAnaheim Clinical Trials LLC - Anaheim - CenExel - PPDS· Anaheim, CACollaborative Neuroscience Network - Los Alamitos- CenExel - PPDS· Los Alamitos, CAAES - DRS - Optimal Research Florida - Melbourne· Melbourne, FLForCare Clinical Research - CenExel FCR - PPDS· Tampa, FLAtlanta Center for Medical Research - CenExel ACMR - PPDS· Atlanta, GA
Related Studies
- Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)PHASE1 · Recruiting · Gilead Sciences · Miami, Florida
- A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMPHASE3 · Not Yet Recruiting · AstraZeneca · Birmingham, Alabama
- An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)Enrolling By Invitation · Novo Nordisk A/S · Morgantown, West Virginia
- How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body TypesRecruiting · George Washington University · Washington D.C., District of Columbia